Serological Biomarkers of Extracellular Matrix Turnover and Neutrophil Activity Are Associated with Long-Term Use of Vedolizumab in Patients with Crohn's Disease.

Int J Mol Sci · 2022 · PMC9329899 · PMID 35897710

Europe PMC DOI

hedged sentence

0.0970

closest p · 1.9× alpha

0.0970

boldest claim

The sentences

showed a trendp = 0.097so close (0.05 < p ≤ 0.1)

C3M showed a trend toward being positively correlated with the SES-CD score (ρ = 0.38, p = 0.097).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.